|Awarded On||August 21, 2019|
|Title||A Targeted Proteomics and Metabolomics Mass Spectrometry Core Facility at the University of Texas Medical Branch at Galveston|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||The University of Texas Medical Branch at Galveston|
|Principal Investigator/Program Director||William K Russell|
|Cancer Sites||All Sites|
*Pending contract negotiation
The goal of this proposal is to provide state-of-the-art mass spectrometry technologies, expertise, and support for Texas cancer investigators. Mass Spectrometry allows investigators to examine molecular level changes in protein and metabolic pathways. The main goals of using mass spectrometry in translational research include detecting disease in the early stages, predicting disease prognosis and identifying targets for new therapeutics. The proposed core will accelerate the molecular level understanding of diseases in order to discover new biomarkers and therapeutic targets using absolute quantification methods. Unlike typical relative quantitative methods, in which relative changes betwee...